Ticker LaunchLondon · AIM · IPO · SBI
SourceBio International plc
SourceBio International plc (SBI) was admitted to AIM on Oct 29, 2020, raising £35M at 162p per share. Its market capitalization at admission was about £120.2M. Liberum Capital Limited acted as nominated adviser.
SourceBio International plc provides laboratory services and products internationally, including COVID-19 testing. It used its AIM IPO proceeds to repay loans and expand testing capacity.
- Type
- IPO
- Market
- AIM
- Ticker (TIDM)
- SBI
- Admitted
- Oct 29, 2020
- Offer price
- 162p
- Raised
- £35M
- Market cap at admission
- £120.2M
- Nominated adviser
- Liberum Capital Limited
- Brokers
- Liberum Capital Limited
- Sector
- Biotech & pharma
- Country
- United Kingdom
More on this listing for subscribers
- Intention-to-float date
- New money versus sale shares
- Shares in issue at admission
- ISIN
- Source announcements
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Sources
From company announcements filed with the FCA's National Storage Mechanism. Subscribers see the list of announcements for each listing.
Other London listings around the same time
- Verici Dx plcAIM · Nov 3, 2020
- Wheaton Precious Metals Corp.Main Market · Oct 28, 2020
- Anemoi International LtdMain Market · Oct 26, 2020
- SDIC Power Holdings Co., LtdMain Market · Oct 22, 2020
- JSC Kaspi.kzMain Market · Oct 20, 2020
- Triple Point Energy Efficiency Infrastructure Company plcMain Market · Oct 19, 2020